INTRODUCTION
In the previous article (Dron & Tovey, 1983) we have described the isolation and characterization of two clones of Daudi cells with markedly reduced sensitivity to both the antiviral and anticellular actions of interferon-a and -ft. Clone DIF3 exhibits a slight decrease in growth rate in the presence of 105 international units/ml of interferon-a, whereas the multiplication of parental Daudi cells is completely inhibited by only 10 units/ml of interferon-a. Clone DIF2 is of intermediate interferon sensitivity. In this article we describe experiments designed to elucidate the mechanisms of interferon resistance of these cells.
METHODS
Cells and cell culture. The isolation and characterization of clones DIF2 and DIE 3 were described by Dron & Tovey (1983) . All cells were cultivated in RPMI 1640 medium with 15~ foetal calf serum (Flow Laboratories, Irvine, Scotland) .
Interferon preparations. The interferon preparations used were the same as those described in the previous article. Purification and radiolabelling of human interferon-~ from Namalwa cells were carried out as described by Mogensen et al. (1981) . 3zsI-IFN-c~ had a titre of 16000 international units/ml and a radioactive content of 75 [tCi/~tg IFN protein at the time of the experiment. Exponentially multiplying cells were incubated for 2 h with different concentrations of ~ '-sI-IFN-c¢ at 37 °C and then immediately placed on ice. Two ml of cell suspension per point was centrifuged at 4 °C and washed twice with 4 ml of RPMI 1640 medium containing 1 ~ foetal calf serum. Cell pellets were transferred for counting (LKB Rackgamma 1270, 80~ efficiency). Bound radioactivity is expressed per l06 cells.
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Assay of2"-5'-oligo-isoadenylate synthetase. Cell extracts were mixed with 50 i.tl of poly(rI)-(rC) agarose (P-L Biochemicals) for 15 min at 30°C and the non-adsorbed material was removed by centrifugation. The poly(rI)-(rC)-adsorbed material was incubated with 2.5 mxt-[ct-32p]ATP, 400 Ci/mmol (Amersham International) for 20 h at 30 °C, treated with bacterial alkaline phosphatase (Sigma) and then eluted from a column of acid alumina (Sigma) (300 lad with 3-0 ml of 1 M-glycine-HCl buffer pH 2.0 as previously described (Merlin et al., 1981) .
Results are expressed as pmol ATP incorporated per h per l0 s cells.
Cyclic nucleotide determination. One ml of cell suspension was treated with 1 ml of 12 ~ trichloroacetic acid for 15 min at 0 °C, centrifuged (2000g, 10 min) and the supernatant was extracted with ether, purified on a column of Dowex AG1X8 (Murad et al., 1971) and assayed for cAMP content using a protein-binding assay as previously described (Rochette-Egly & Castagna, 1977) , and for cyclic GMP content using a radioimmune assay (Amersham International). Recovery (70 to 80%) was monitored with 1 nCi of [3H]cyclic AMP or [3H]cyclic GMP. Results are expressed as the mean of four replicates in pmol per 106 ceils.
RESULTS

Binding of tZSl-interferon-~ to Daudi cells and interferon-resistant clones
To determine whether the interferon resistance of clones DIF2 and DIF3 was due to the absence of functional interferon receptors the direct binding at 37 °C of radiolabelled IFN-c< at equilibrium to clones DIFz and DIF3 was compared with that to parental Daudi cells ( 
Determination of the influence of soluble factor(s)produced by DIF 3 cells on the interferon sensitivity of Daudi cells
To determine whether the phenotype of interferon resistance was due to the production by DIF3 cells of a soluble factor capable of either inactivating interferon at the cell surface or inhibiting its action, Daudi cells were treated with interferon in the presence of increasing concentrations of nutrient medium in which DIF 3 cells had been cultivated. This treatment had no effect on the sensitivity of Daudi cells to the antiproliferative action of interferon (data not shown).
Induction of cyclic nucleotides
The binding of interferon to its specific cell surface receptor is followed by a rapid increase in the intraceUular concentratioh of cyclic GMP (Tovey et al., 1979; Tovey & Rochette-Egly, 1981 ; Tovey, 1982) . Treatment of Daudi cells with electrophoretically pure IFN-~ caused a rapid increase in the intracellular concentration of cyclic GMP within 1 to 5 min (Table 1) . A similar increase in the intracellular concentration of cyclic GMP was observed when Daudi cells were treated with sodium azide, a non-physiological activator of guanylate cyclase (Table 1) . No increase in cyclic GMP was observed when clones DIF2 and DIF3 were treated with either IFN or sodium azide (Table 1) . Indeed, some decrease in the intraceUular concentration of cyclic GMP was observed in DIF3 cells following treatment with either interferon or sodium azide (Table 1) .
2'-5'-Oligo-isoadenylate synthetase activity in Daudi cells and interferon-resistant clones
In agreement with previous reports (Krishnan & Baglioni, 1980; Tomita et al., 1982; Silverman et al., 1982) Daudi cells were found to contain high levels of endogenous 2'-5'-oligoisoadenylate synthetase activity (Fig. 2) , which was enhanced several-fold following treatment with highly purified human interferon-or (Fig. 2) . The level of endogenous 2'-5'-oligoisoadenylate synthetase activity in DIF2 and DIF3 cells was similar to that found in parental -Daudi cells although in all three cell lines the basal level of the enzyme varied considerably from one experiment to another. An increase in 2'-5'-oligo-isoadenylate synthetase activity was also observed in both DIF2 and DIF3 cells following interferon treatment (Table 2 ). The level of 2'-5' A phosphodiesterase activity was similar in all three cell lines and did not change significantly following interferon treatment (data not shown). 
DISCUSSION
Cells have been isolated in which the phenotype of interferon resistance has been shown to be due to the lack of a functional receptor for interferons-a and -fl (Aguet, 1980; Aguet & Blanchard, 1981) . Receptor binding studies carried out at 37 °C, where binding is a function of the activity of the interferon-receptor complex (Mogensen & Bandu, 1983) , suggest that the interferon-carrying capacity of the cellular receptors is unimpaired in the interferon-resistant Daudi cell clones, DIF2 and DIF3.
The interferon-resistant clones, in contrast to parental Daudi cells, do not exhibit elevated levels of cyclic GMP following interferon treatment. However, these cells do not respond either to sodium azide a non-physiological inducer of cyclic GMP, and it remains to be established whether these changes are related to the phenotype of interferon resistance.
Interferon induces a number of cellular proteins including 2'-5'-oligo-isoadenylate synthetase, a double-stranded RNA-activated enzyme that synthesizes a series of oligonucleotides of general structure ppp(A2'p)nA. The products of the synthetase activate at subnanomolar concentrations an endoribonuclease leading to inhibition of protein synthesis. This system has been implicated in both the antiviral and antiproliferative actions of interferon (Kerr et al., 1981 ; Lengyel, 1981 ; Lebleu & Content, 1982) . The levels of both endogenous and interferon-induced 2'-5'-oligo-isoadenylate synthetase activity, and ppp(A2'p),A degradation are similar in Daudi cells and the interferon-resistant clones, suggesting that the decreased interferon sensitivity of DIF2 and DIF3 cells is not due to a lack of ppp(A2'p),A. However, this remains to be established by direct measurement of intracellular ppp(A2'p)nA in virus-infected or growtharrested cells. Silverman et al. (1982) were unable to detect ppp(A2'p)nA in interferon-treated wild-type or resistant Daudi cells isolated by a different procedure, again:arguing against an
